Drug Profile
Research programme: nicotinic acetylcholine receptor agonists - Odan Laboratories
Alternative Names: ASM-002; nAchR agonists - Odan LaboratoriesLatest Information Update: 28 Jan 2018
Price :
$50
*
At a glance
- Originator Asmacure
- Developer Odan Laboratories
- Class Small molecules
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Allergic asthma